ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 82 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2020$361,000
+184.3%
104,400
+615.1%
0.00%
Q2 2020$127,00014,6000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders